US Offers Investment To Boost COVID-19 Vaccine Production

WASHINGTON – The Biden administration is making billions of dollars available to drug makers to increase domestic production of COVID-19 vaccines. The goal is to develop the capacity to produce an additional 1 billion injections per year to share with the world. Under the new initiative, the Department of Health and Human Services’ Advanced Biomedical Research and Development Authority is soliciting pharmaceutical companies that have demonstrated the ability to make more effective mRNA vaccines to bid for government investments to expand their manufacturing capabilities. Drug makers Pfizer and Moderna produce the two US-approved mRNA injections.The Biden government believes that the enhanced capacity of COVID-19 injections will help alleviate global dose shortages, particularly in low-income countries. and medium, halting preventable deaths and limiting the development of potentially new and more dangerous variants of the virus. The initiative comes as the Biden White House has faced mounting pressure at home and abroad over inequality in the global supply of vaccines, as the United States moves toward approving booster vaccines for all adults as vulnerable people in the poorest nations await their first dose of protection. There are still no firm agreements with Moderna or Pfizer to assume the investment in the US, but the Biden management hopes that the improved manufacturing capacity, through support to the company’s facilities, equipment, personnel or training, will be available. by mid-2022 to allow more doses of COVID-19 to be shared abroad, as well as to prepare for the next public health emergency. The announcement was made Wednesday by an administration official who spoke on condition of anonymity prior to the official statement. The New York Times first reported on the new initiative. Connect with the ! Subscribe to our YouTube channel and activate notifications, or follow us on social networks: Facebook, Twitter

and Instagram.